Latest News about ABBV
Recent news which mentions ABBV
Decoding AbbVie's Options Activity: What's the Big Picture?
December 14, 2023
Tickers
ABBV
From Benzinga
The 7 Most Undervalued Growth Stocks to Buy in December
December 13, 2023
From InvestorPlace
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
December 13, 2023
Tickers
ABBV
From Benzinga
Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability
December 13, 2023
From InvestorPlace
Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings
December 12, 2023
From Benzinga
From Motley Fool
From Benzinga
The 3 Best Cheap Stocks to Buy in December
December 10, 2023
From InvestorPlace
From Motley Fool
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?
December 10, 2023
From Motley Fool
3 Dividend Stocks You Can Safely Hold for Decades
December 09, 2023
From Motley Fool
Better Dividend Stock: AbbVie vs. Medical Properties Trust
December 09, 2023
From Motley Fool
3 High-Yielding Dividend Stocks That Are Near Their 52-Week Lows
December 08, 2023
From Motley Fool
From Motley Fool
Healthcare Gems: 3 Essential Long-Term Stock Picks
December 07, 2023
From InvestorPlace
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
December 07, 2023
From Benzinga
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 07, 2023
From Benzinga
Why Cerevel Therapeutics Stock Is Higher
December 07, 2023
From Benzinga
Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday
December 07, 2023
From Benzinga
These are the dividend stocks that will hold up in a weakening economy in 2024, says this highly rated money manager
December 07, 2023
From MarketWatch
Why Is Cerevel Therapeutics (CERE) Stock Up 12% Today?
December 07, 2023
From InvestorPlace
Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
December 07, 2023
From Benzinga
There’s a new market dynamic heading into payrolls report, Goldman trading expert says
December 07, 2023
From MarketWatch
Is AbbVie Stock a Buy Now?
December 07, 2023
From Motley Fool
Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?
December 07, 2023
From Motley Fool
From Motley Fool
Why Cerevel Therapeutics Holdings Is Moving After-Hours
December 06, 2023
From Benzinga
AbbVie to buy Cerevel Therapeutics in $8.7 billion all-cash deal
December 06, 2023
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.